SPARK Neuro Competitors and Similar CompaniesClear all
SPARK Neuro's competitors and similar companies include Express Diagnostics Int'l, SurModics and Inflazome.
 SPARK Neuro SPARK Neuro is a neuroscience company that provides drug development and clinical care solutions. |  Express Diagnostics Int'l Express Diagnostics Int'l is a company that manufactures and distributes DrugCheck, onsite urine and saliva screening devices for the detection of drugs of abuse. |  SurModics SurModics is a provider of surface modification, drug delivery and in vitro diagnostic technologies to the healthcare industry. |  Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | |
Founding Date | Founding Date 2016 | Founding Date 2004 | Founding Date 1979 | Founding Date 2016 |
Type | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Santa Monica, US HQ | Locations Blue Earth, US HQ | Locations Eden Prairie, US HQ Galway, IE Eden Prairie, US | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB |
Employees | Employees 234% decrease | Employees 17 | Employees 3699% increase | Employees 156% decrease |
Valuation ($) | Valuation ($) 53.5 m | Valuation ($) N/A | Valuation ($) 539.3 m | Valuation ($) N/A |
Funding | ||||
Total funding raised | Total funding raised $ 13.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 17m |
For sources of this data, please see the company profile
View Company Profiles
Express Diagnostics Int'l
HQ
Blue Earth, US
Employees
17
Express Diagnostics Int'l is a company that manufactures and distributes DrugCheck, onsite urine and saliva screening devices for the detection of drugs of abuse.
View companySurModics
HQ
Eden Prairie, US
Employees
369↑ 9% increase
SurModics is a provider of surface modification, drug delivery and in vitro diagnostic technologies to the healthcare industry.
View companyInflazome
HQ
Dublin 2, IE
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View company